Drugs Made In America Acquisition (DMII) Financials: Revenue & Earnings
DMII$10.20+0.01 +0.10%
$649.74M
Market Cap
—
P/E
—
Forward P/E
—
Score
Drugs Made In America Acquisition (DMII) Financials: Revenue & Earnings
DMII price $10.20 +0.01 +0.10%
- Ticker
- DMII
- Price
- $10.20
- Change
- +0.01 +0.10%
- Market cap ?
- $649.74M
- Beta ?
- 0.04
- Sector
- Financial Services
- Industry
- Financial - Conglomerates
Fair value
DMII fair value $2.85. Price $10.20. Price is 258% above fair value.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Model uncertainty high for this stock
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| No data yet. | ||||
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| No data yet. | |||||
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 70, holders +2 vs prior quarter. Ownership 90.96%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| KARPUS MANAGEMENT, INC. | 2.79M | 190.07K | +7.32% | 28.05M |
| MAGNETAR FINANCIAL LLC | 2.70M | 0 | 0.00% | 27.16M |
| MMCAP INTERNATIONAL INC. SPC | 2.70M | 0 | 0.00% | 27.16M |
| GLAZER CAPITAL, LLC | 2.34M | -6.48K | -0.28% | 23.57M |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 2.24M | 2.02M | +896.08% | 22.57M |
| MILLENNIUM MANAGEMENT LLC | 1.99M | 17.13K | +0.87% | 20.06M |
| HUDSON BAY CAPITAL MANAGEMENT LP | 1.97M | 0 | 0.00% | 19.81M |
| WOLVERINE ASSET MANAGEMENT LLC | 1.86M | 59.93K | +3.34% | 18.66M |
| POLAR ASSET MANAGEMENT PARTNERS INC. | 1.50M | 0 | 0.00% | 15.09M |
| TENOR CAPITAL MANAGEMENT CO., L.P. | 1.50M | 0 | 0.00% | 15.09M |
| D. E. SHAW & CO., INC. | 1.48M | 84.90K | +6.11% | 14.84M |
| AQR ARBITRAGE LLC | 1.13M | 18.88K | +1.70% | 11.38M |
| CROSSINGBRIDGE ADVISORS, LLC | 1.10M | 750.00K | +214.29% | 11.07M |
| ARISTEIA CAPITAL, L.L.C. | 1.10M | 0 | 0.00% | 11.07M |
| FIRST TRUST CAPITAL MANAGEMENT L.P. | 1.07M | 0 | 0.00% | 10.74M |
| OMERS ADMINISTRATION CORP | 1.00M | 0 | 0.00% | 10.06M |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 1.00M | 0 | 0.00% | 10.06M |
| PICTON MAHONEY ASSET MANAGEMENT | 888.00K | 13.00K | +1.49% | 8.93M |
| TWO SIGMA INVESTMENTS, LP | 886.54K | 0 | 0.00% | 8.92M |
| MOORE CAPITAL MANAGEMENT, LP | 750.00K | 0 | 0.00% | 7.54M |
| CONTEXT CAPITAL MANAGEMENT, LLC | 750.00K | 0 | 0.00% | 7.54M |
| GHISALLO CAPITAL MANAGEMENT LLC | 750.00K | 0 | 0.00% | 7.54M |
| MERCURIA CAPITAL STRATEGIES, LLC | 750.00K | 0 | 0.00% | 7.54M |
| WESTCHESTER CAPITAL MANAGEMENT, LLC | 621.80K | 121.79K | +24.36% | 6.26M |
| RADCLIFFE CAPITAL MANAGEMENT, L.P. | 575.72K | 0 | 0.00% | 5.79M |
Earnings and financials
Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) trades at $10.20, with a market cap of $649.74M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Insights · Dividends · Forecast · Financials · Learn